The DOI matches its Crossref record; 320 of the 320 references it cites were found in a registry or an index.
Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Open accessAbstract
This document updates and expands the initial Infectious Diseases Society of America (IDSA) Fever and Neutropenia Guideline that was published in 1997 and first updated in 2002. It is intended as a guide for the use of antimicrobial agents in managing patients with cancer who experience chemotherapy-induced fever and neutropenia. Recent advances in antimicrobial drug development and technology, clinical trial results, and extensive clinical experience have informed the approaches and recommendations herein. Because the previous iteration of this guideline in 2002, we have a developed a clearer definition of which populations of patients with cancer may benefit most from antibiotic, antifungal, and antiviral prophylaxis. Furthermore, categorizing neutropenic patients as being at high risk or low risk for infection according to presenting signs and symptoms, underlying cancer, type of therapy, and medical comorbidities has become essential to the treatment algorithm. Risk stratification is a recommended starting point for managing patients with fever and neutropenia. In addition, earlier detection of invasive fungal infections has led to debate regarding optimal use of empirical or preemptive antifungal therapy, although algorithms are still evolving. What has not changed is the indication for immediate empirical antibiotic therapy. It remains true that all patients who present with fever and neutropenia should be treated swiftly and broadly with antibiotics to treat both gram-positive and gram-negative pathogens. Finally, we note that all Panel members are from institutions in the United States or Canada; thus, these guidelines were developed in the context of North American practices. Some recommendations may not be as applicable outside of North America, in areas where differences in available antibiotics, in the predominant pathogens, and/or in health care–associated economic conditions exist. Regardless of venue, clinical vigilance and immediate treatment are the universal keys to managing neutropenic patients with fever and/or infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Mermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Self-citationSiegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Self-citationBODEY, G. P., BUCKLEY, M., SATHE, Y. S., & FREIREICH, E. J. (1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-2-328 · Cited by 2,469
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Self-citationPosaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813
Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. A. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,797
Self-citationIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
Smith, T. J., Khatcheressian, J., Lyman, G. H., Ozer, H., Armitage, J. O., Balducci, L., Bennett, C. L., Cantor, S. B., Crawford, J., Cross, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4451 · Cited by 1,636
Maki, D. G., Kluger, D. M., & Crnich, C. J. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.9.1159 · Cited by 1,549
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P., Langston, A., Tarantolo, S. R., Greinix, H., Morais de Azevedo, W., Reddy, V., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,345
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
Kuderer, N. M., Dale, D. C., Crawford, J., Cosler, L. E., & Lyman, G. H. (2006) · Cancer · doi:10.1002/cncr.21847 · Cited by 1,176
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Klastersky, J., Paesmans, M., Rubenstein, E. B., Boyer, M., Elting, L., Feld, R., Gallagher, J., Herrstedt, J., Rapoport, B., Rolston, K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.3038 · Cited by 1,171
Self-citationPepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979
Self-citationDiagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-Analysis
Pfeiffer, C. D., Fine, J. P., & Safdar, N. (2006) · Clinical Infectious Diseases · doi:10.1086/503427 · Cited by 962
Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszynska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 919
(2006) · PubMed · Cited by 906
Pascual, A., Calandra, T., Bolay, S., Buclin, T., Bille, J., & Marchetti, O. (2008) · Clinical Infectious Diseases · doi:10.1086/524669 · Cited by 887
Pizzo, P. A., Robichaud, K. J., Gill, F. A., & Witebsky, F. G. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90594-0 · Cited by 859
Slavin, M. A., Osborne, B., Adams, R., Levenstein, M. J., Schoch, H. G., Feldman, A. R., Meyers, J. D., & Bowden, R. A. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1545 · Cited by 820
Raad, I. I., Hohn, D. C., Gilbreath, B. J., Suleiman, N., Hill, L. A., Bruso, P. A., Marts, K., Mansfield, P. F., & Bodey, G. P. (1994) · Infection Control & Hospital Epidemiology · doi:10.1086/646902 · Cited by 774
Self-citationGERSON, S. L., TALBOT, G. H., HURWITZ, S., STROM, B. L., LUSK, E. J., & CASSILETH, P. A. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-3-345 · Cited by 763
van Burik, J.-A. H., Ratanatharathorn, V., Stepan, D. E., Miller, C. B., Lipton, J. H., Vesole, D. H., Bunin, N., Wall, D. A., Hiemenz, J. W., Satoi, Y., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/422312 · Cited by 744
Kuderer, N. M., Dale, D. C., Crawford, J., & Lyman, G. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8823 · Cited by 720
Caillot, D., Casasnovas, O., Bernard, A., Couaillier, J. F., Durand, C., Cuisenier, B., Solary, E., Piard, F., Petrella, T., Bonnin, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.139 · Cited by 706
Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.760-766.2005 · Cited by 692
Wisplinghoff, H., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2003) · Clinical Infectious Diseases · doi:10.1086/374339 · Cited by 687
Ostrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432470 · Cited by 669
Self-citationLevofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
Bucaneve, G., Micozzi, A., Menichetti, F., Martino, P., Dionisi, M. S., Martinelli, G., Allione, B., D'Antonio, D., Buelli, M., Nosari, A. M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044097 · Cited by 648
Odabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian, H., Saeki, F., Ridge, R. J., Ketchum, P. A., Finkelman, M. A., Rex, J. H., & Ostrosky-Zeichner, L. (2004) · Clinical Infectious Diseases · doi:10.1086/421944 · Cited by 642
Dykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Inadequate Antimicrobial Treatment: An Important Determinant of Outcome for Hospitalized Patients
Kollef, M. H. (2000) · Clinical Infectious Diseases · doi:10.1086/314079 · Cited by 635
Muto, C. A., Pokrywka, M., Shutt, K., Mendelsohn, A. B., Nouri, K., Posey, K., Roberts, T., Croyle, K., Krystoflak, S., Patel-Brown, S., et al. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502539 · Cited by 619
Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign
Greene, R. E., Schlamm, H. T., Oestmann, J.-W., Stark, P., Durand, C., Lortholary, O., Wingard, J. R., Herbrecht, R., Ribaud, P., Patterson, T. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/509917 · Cited by 594
Self-citationMaertens, J., Theunissen, K., Verhoef, G., Verschakelen, J., Lagrou, K., Verbeken, E., Wilmer, A., Verhaegen, J., Boogaerts, M., & Eldere, J. V. (2005) · Clinical Infectious Diseases · doi:10.1086/496927 · Cited by 592
Saral, R., Burns, W. H., Laskin, O. L., Santos, G. W., & Lietman, P. S. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107093050202 · Cited by 591
Caillot, D., Couaillier, J.-F., Bernard, A., Casasnovas, O., Denning, D. W., Mannone, L., Lopez, J., Couillault, G., Piard, F., Vagner, O., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.253 · Cited by 587
Pizzo, P. A., Hathorn, J. W., Hiemenz, J., Browne, M., Commers, J., Cotton, D., Gress, J., Longo, D., Marshall, D., McKnight, J., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608283150905 · Cited by 585
Raad, I., Costerton, W., Sabharwal, U., Sadlowski, M., Anaissie, E., & Bodey, G. P. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/168.2.400 · Cited by 553
Self-citationDetection of Bloodstream Infections in Adults: How Many Blood Cultures Are Needed?
Lee, A., Mirrett, S., Reller, L. B., & Weinstein, M. P. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01555-07 · Cited by 548
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Casellas, J. M., Mulazimoglu, L., Klugman, K. P., Bonomo, R. A., Rice, L. B., McCormack, J. G., & Yu, V. L. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.6.2206-2212.2001 · Cited by 546
Talcott, J. A., Siegel, R. D., Finberg, R., & Goldman, L. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.2.316 · Cited by 545
Aapro, M. S., Cameron, D. A., Pettengell, R., Bohlius, J., Crawford, J., Ellis, M., Kearney, N., Lyman, G. H., Tjan-Heijnen, V. C., Walewski, J., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.05.002 · Cited by 539
Wingard, J. R., White, M. H., Anaissie, E., Raffalli, J., Goodman, J., Arrieta, A., & L Amph/ABLC Collaborative Study Group (2000) · Clinical Infectious Diseases · doi:10.1086/317451 · Cited by 527
Self-citationKullberg, B., Sobel, J., Ruhnke, M., Pappas, P., Viscoli, C., Rex, J., Cleary, J., Rubinstein, E., Church, L., Brown, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67490-9 · Cited by 521
Kunisaki, K. M., & Janoff, E. N. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70175-6 · Cited by 516
Maertens, J., Verhaegen, J., Lagrou, K., Van Eldere, J., & Boogaerts, M. (2001) · Blood · doi:10.1182/blood.v97.6.1604 · Cited by 513
Marr, K. A., Seidel, K., Slavin, M. A., Bowden, R. A., Schoch, H. G., Flowers, M. E. D., Corey, L., & Boeckh, M. (2000) · Blood · doi:10.1182/blood.v96.6.2055 · Cited by 511
Self-citationMeta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients
Gafter-Gvili, A., Fraser, A., Paul, M., & Leibovici, L. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_1-200506210-00008 · Cited by 499
Galactomannan in Bronchoalveolar Lavage Fluid
Meersseman, W., Lagrou, K., Maertens, J., Wilmer, A., Hermans, G., Vanderschueren, S., Spriet, I., Verbeken, E., & Van Wijngaerden, E. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200704-606oc · Cited by 496
Laboratory diagnosis of invasive aspergillosis
Hope, W., Walsh, T., & Denning, D. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70238-3 · Cited by 495
Marr, K. A., Balajee, S. A., McLaughlin, L., Tabouret, M., Bentsen, C., & Walsh, T. J. (2004) · The Journal of Infectious Diseases · doi:10.1086/422009 · Cited by 483
Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis
Mennink-Kersten, M. A., Donnelly, J. P., & Verweij, P. E. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01045-x · Cited by 482
Antifungal Therapy Decreases Sensitivity of theAspergillus Galactomannan Enzyme Immunoassay
Marr, K. A., Laverdiere, M., Gugel, A., & Leisenring, W. (2005) · Clinical Infectious Diseases · doi:10.1086/429921 · Cited by 471
Kuhlman, J. E., Fishman, E. K., & Siegelman, S. S. (1985) · Radiology · doi:10.1148/radiology.157.3.3864189 · Cited by 448
Marr, K. A., Crippa, F., Leisenring, W., Hoyle, M., Boeckh, M., Balajee, S. A., Nichols, W. G., Musher, B., & Corey, L. (2004) · Blood · doi:10.1182/blood-2003-08-2644 · Cited by 442
Self-citationFowler, V. G., Sanders, L. L., Sexton, D. J., Kong, L., Marr, K. A., Gopal, A. K., Gottlieb, G., McClelland, R. S., & Corey, G. R. (1998) · Clinical Infectious Diseases · doi:10.1086/514686 · Cited by 441
Blot, F., Nitenberg, G., Chachatty, E., Raynard, B., Germann, N., Antoun, S., Laplanche, A., Brun-Buisson, C., & Tancrède, C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11134-0 · Cited by 438
Optimal Testing Parameters for Blood Cultures
Cockerill, F. R., Wilson, J. W., Vetter, E. A., Goodman, K. M., Torgerson, C. A., Harmsen, W. S., Schleck, C. D., Ilstrup, D. M., Washington, J. A., & Wilson, W. R. (2004) · Clinical Infectious Diseases · doi:10.1086/421087 · Cited by 435
Rosenberg, P. S. (2006) · Blood · doi:10.1182/blood-2005-11-4370 · Cited by 431
Revisiting the source of candidemia: skin or gut?
Nucci, M., & Anaissie, E. (2001) · Clinical Infectious Diseases · doi:10.1086/323759 · Cited by 424
Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas
Cullen, M., Steven, N., Billingham, L., Gaunt, C., Hastings, M., Simmonds, P., Stuart, N., Rea, D., Bower, M., Fernando, I., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050078 · Cited by 422
Zinner, S. H. (1999) · Clinical Infectious Diseases · doi:10.1086/598620 · Cited by 417
Safdar, N., Handelsman, J., & Maki, D. G. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01108-9 · Cited by 417
Freifeld, A., Marchigiani, D., Walsh, T., Chanock, S., Lewis, L., Hiemenz, J., Hiemenz, S., Hicks, J. E., Gill, V., Steinberg, S. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907293410501 · Cited by 402
Self-citationTreatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa
Rossolini, G. M., & Mantengoli, E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01161.x · Cited by 395
Aspergillus Galactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer Patients
Herbrecht, R., Letscher-Bru, V., Oprea, C., Lioure, B., Waller, J., Campos, F., Villard, O., Liu, K.-L., Natarajan-Amé, S., Lutz, P., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.004 · Cited by 392
Winston, D. J., Maziarz, R. T., Chandrasekar, P. H., Lazarus, H. M., Goldman, M., Blumer, J. L., Leitz, G. J., & Territo, M. C. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-9-200305060-00006 · Cited by 389
Cordonnier, C., Pautas, C., Maury, S., Vekhoff, A., Farhat, H., Suarez, F., Dhédin, N., Isnard, F., Ades, L., Kuhnowski, F., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597395 · Cited by 389
Elting, L. S., Rubenstein, E. B., Rolston, K. V. I., & Bodey, G. P. (1997) · Clinical Infectious Diseases · doi:10.1086/514550 · Cited by 385
Self-citationAntimicrobial resistance in gram-positive bacteria
Rice, L. B. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.220 · Cited by 381
Elting, L. S., Bodey, G. P., & Keefe, B. H. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.6.1201 · Cited by 377
Nichols, W. G., Guthrie, K. A., Corey, L., & Boeckh, M. (2004) · Clinical Infectious Diseases · doi:10.1086/425004 · Cited by 377
Self-citationKern, W. V., Cometta, A., de Bock, R., Langenaeken, J., Paesmans, M., Zanetti, G., Calandra, T., Glauser, M. P., Crokaert, F., Klastersky, J., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907293410502 · Cited by 370
Nguyen, M. H. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430220087009 · Cited by 363
Talcott, J. A. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.12.2561 · Cited by 363
Fungal infections in patients with acute leukemia
Degregorio, M. W., Lee, W. M. F., Linker, C. A., Jacobs, R. A., & A. Ries, C. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90334-5 · Cited by 354
Raad, I., Hanna, H. A., Alakech, B., Chatzinikolaou, I., Johnson, M. M., & Tarrand, J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-1-200401060-00007 · Cited by 354
Self-citationBacteraemia in febrile neutropenic cancer patients
Klastersky, J., Ameye, L., Maertens, J., Georgala, A., Muanza, F., Aoun, M., Ferrant, A., Rapoport, B., Rolston, K., & Paesmans, M. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.06.012 · Cited by 347
Self-citationMaertens, J., Van Eldere, J., Verhaegen, J., Verbeken, E., Verschakelen, J., & Boogaerts, M. (2002) · The Journal of Infectious Diseases · doi:10.1086/343804 · Cited by 343
Hachem, R., Hanna, H., Kontoyiannis, D., Jiang, Y., & Raad, I. (2008) · Cancer · doi:10.1002/cncr.23466 · Cited by 331
Self-citationMeta-Analysis: Methods for Diagnosing Intravascular Device–Related Bloodstream Infection
Safdar, N., Fine, J. P., & Maki, D. G. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-6-200503150-00011 · Cited by 329
Weinstein, M. P. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.1.40 · Cited by 324
Boogaerts, M., Winston, D. J., Bow, E. J., Garber, G., Reboli, A. C., Schwarer, A. P., Novitzky, N., Boehme, A., Chwetzoff, E., De Beule, K., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00010 · Cited by 321
Self-citationVergis, E. N., Hayden, M. K., Chow, J. W., Snydman, D. R., Zervos, M. J., Linden, P. K., Wagener, M. M., Schmitt, B., & Muder, R. R. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-7-200110020-00007 · Cited by 319
Lodise, T. P., Patel, N., Kwa, A., Graves, J., Furuno, J. P., Graffunder, E., Lomaestro, B., & McGregor, J. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00338-07 · Cited by 318
Clark, O. A. C., Lyman, G. H., Castro, A. A., Clark, L. G. O., & Djulbegovic, B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.645 · Cited by 310
Robenshtok, E., Gafter-Gvili, A., Goldberg, E., Weinberger, M., Yeshurun, M., Leibovici, L., & Paul, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3851 · Cited by 298
Detection of Bacteremia in Adults: Consequences of Culturing an Inadequate Volume of Blood
Mermel, L. A., & Maki, D. G. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-4-199308150-00003 · Cited by 294
Nichols, W. G., Corey, L., Gooley, T., Davis, C., & Boeckh, M. (2001) · Blood · doi:10.1182/blood.v98.3.573 · Cited by 290
Self-citationBlot, F., Schmidt, E., Nitenberg, G., Tancrède, C., Leclercq, B., Laplanche, A., & Andremont, A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.1.105-109.1998 · Cited by 289
Management of Fever in Neutropenic Patients with Different Risks of Complications
Klastersky, J. (2004) · Clinical Infectious Diseases · doi:10.1086/383050 · Cited by 287
Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer
Rubenstein, E. B., Rolston, K., Escalante, C., Manzullo, E., Hughes, P., Fender, A., Elting, L., Bodey, G. P., Holmes, F., Loewy, J., et al. (1993) · Cancer · doi:10.1002/1097-0142(19930601)71:11<3640::aid-cncr2820711128>3.0.co;2-h · Cited by 286
Self-citationYokoe, D. S., Mermel, L. A., Anderson, D. J., Arias, K. M., Burstin, H., Calfee, D. P., Coffin, S. E., Dubberke, E. R., Fraser, V., Gerding, D. N., et al. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591060 · Cited by 280
Messing, B., Peitra‐Cohen, S., Debure, A., Beliah, M., & Bernier, J. (1988) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607188012002185 · Cited by 277
Cometta, A., Calandra, T., Gaya, H., Zinner, S. H., de Bock, R., Del Favero, A., Bucaneve, G., Crokaert, F., Kern, W. V., Klastersky, J., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1108 · Cited by 275
Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4574-4581.2004 · Cited by 267
Efficacy and safety of cefepime: a systematic review and meta-analysis
Yahav, D., Paul, M., Fraser, A., Sarid, N., & Leibovici, L. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70109-3 · Cited by 265
Rotstein, C., Bow, E. J., Laverdiere, M., Ioannou, S., Carr, D., Moghaddam, N., & The Canadian Fluconazole Prophylaxis Study Group (1999) · Clinical Infectious Diseases · doi:10.1086/515128 · Cited by 265
Self-citationGlasmacher, A., Prentice, A., Gorschlüter, M., Engelhart, S., Hahn, C., Djulbegovic, B., & Schmidt-Wolf, I. G. H. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.052 · Cited by 264
Senn, L., Robinson, J. O., Schmidt, S., Knaup, M., Asahi, N., Satomura, S., Matsuura, S., Duvoisin, B., Bille, J., Calandra, T., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/527382 · Cited by 263
Neutropenic enterocolitis in adults: systematic analysis of evidence quality
Gorschlüter, M., Mey, U., Strehl, J., Ziske, C., Schepke, M., Schmidt‐Wolf, I. G. H., Sauerbruch, T., & Glasmacher, A. (2005) · European Journal of Haematology · doi:10.1111/j.1600-0609.2005.00442.x · Cited by 262
The American Journal of Medicine
(2015) · Wilderness & Environmental Medicine · doi:10.1016/j.wem.2015.06.005 · Cited by 260
Bow, E. J., Laverdière, M., Lussier, N., Rotstein, C., Cheang, M. S., & Ioannou, S. (2002) · Cancer · doi:10.1002/cncr.10610 · Cited by 258
Self-citationEfficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.
Engels, E. A., Lau, J., & Barza, M. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1179 · Cited by 256
Boeckh, M., Kim, H. W., Flowers, M. E. D., Meyers, J. D., & Bowden, R. A. (2006) · Blood · doi:10.1182/blood-2005-09-3624 · Cited by 255
Self-citationRamphal, R. (2004) · Clinical Infectious Diseases · doi:10.1086/383048 · Cited by 252
Antimicrobial therapy of unexplained fever in neutropenic patients
Link, H., B�hme, A., Cornely, O. A., H�ffken, K., Kellner, O., Kern, W. V., Mahlberg, R., Maschmeyer, G., Nowrousian, M. R., Ostermann, H., et al. (2003) · Annals of Hematology · doi:10.1007/s00277-003-0764-4 · Cited by 251
Prophylaxis with Fluoroquinolones for Bacterial Infections in Neutropenic Patients: A Meta-Analysis
Cruciani, M., Rampazzo, R., Malena, M., Lazzarini, L., Todeschini, G., Messori, A., & Concia, E. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.4.795 · Cited by 250
Mortality and Cancer Incidence Among Individuals With Down Syndrome
Hill, D. A., Gridley, G., Cnattingius, S., Mellemkjaer, L., Linet, M., Adami, H.-O., Olsen, J. H., Nyren, O., & Fraumeni, J. F. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.6.705 · Cited by 247
European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group, & National Cancer Institute of Canada-Clinical Trials Group (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.5.951 · Cited by 246
“Low-Risk” Prediction Rule for Pediatric Oncology Patients Presenting With Fever and Neutropenia
Klaassen, R. J., Goodman, T. R., Pham, B., & Doyle, J. J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1012 · Cited by 234
Clancy, C. J., Jaber, R. A., Leather, H. L., Wingard, J. R., Staley, B., Wheat, L. J., Cline, C. L., Rand, K. H., Schain, D., Baz, M., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00077-07 · Cited by 232
Self-citationTrifilio, S., Singhal, S., Williams, S., Frankfurt, O., Gordon, L., Evens, A., Winter, J., Tallman, M., Pi, J., & Mehta, J. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705754 · Cited by 229
De Pauw, B. E., Deresinski, S. C., Feld, R., Lane-Allman, E. F., & Donnelly, J. P. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-10-199405150-00004 · Cited by 228
Sulahian, A., Boutboul, F., Ribaud, P., Leblanc, T., Lacroix, C., & Derouin, F. (2001) · Cancer · doi:10.1002/1097-0142(20010115)91:2<311::aid-cncr1003>3.0.co;2-3 · Cited by 226
Predicting the risk of bacteremia in childen with fever and neutropenia.
Rackoff, W. R., Gonin, R., Robinson, C., Kreissman, S. G., & Breitfeld, P. B. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.919 · Cited by 223
Malik, I. A., Khan, W. A., Karim, M., Aziz, Z., & Ata Khan, M. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80367-2 · Cited by 221
Peck, A. J., Englund, J. A., Kuypers, J., Guthrie, K. A., Corey, L., Morrow, R., Hackman, R. C., Cent, A., & Boeckh, M. (2007) · Blood · doi:10.1182/blood-2006-12-060343 · Cited by 212
Self-citationFreifeld, A. G., Walsh, T., Marshall, D., Gress, J., Steinberg, S. M., Hathorn, J., Rubin, M., Jarosinski, P., Gill, V, & Young, R. C. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.165 · Cited by 211
Self-citationValue of differential quantitative blood cultures in the diagnosis of catheter-related sepsis
Capdevila, J. A., Planes, A. M., Palomar, M., Gasser, I., Almirante, B., Pahissa, A., Crespo, E., & Martínez-Vázquez, J. M. (1992) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01961854 · Cited by 210
Weinstock, D. M., Conlon, M., Iovino, C., Aubrey, T., Gudiol, C., Riedel, E., Young, J. W., Kiehn, T. E., & Zuccotti, G. (2007) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2007.01.078 · Cited by 208
Self-citationAntibiotic prophylaxis in neutropenic patients: New evidence, practical decisions
Leibovici, L., Paul, M., Cullen, M., Bucaneve, G., Gafter‐Gvili, A., Fraser, A., & Kern, W. V. (2006) · Cancer · doi:10.1002/cncr.22205 · Cited by 203
Robertson, J. D., Nagesh, K., Jowitt, S. N., Dougal, M., Anderson, H., Mutton, K., Zambon, M., & Scarffe, J. H. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1088 · Cited by 199
(1995) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(05)80058-6 · Cited by 197
Maher, D. W., Lieschke, G. J., Green, M., Bishop, J., Stuart-Harris, R., Wolf, M., Sheridan, W. P., Kefford, R. F., Cebon, J., Olver, I., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-7-199410010-00004 · Cited by 196
Krishna, G., Martinho, M., Chandrasekar, P., Ullmann, A. J., & Patino, H. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.12.1627 · Cited by 195
Klastersky, J., Paesmans, M., Georgala, A., Muanza, F., Plehiers, B., Dubreucq, L., Lalami, Y., Aoun, M., & Barette, M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.9909 · Cited by 195
SARAL, R., AMBINDER, R. F., BURNS, W. H., ANGELOPULOS, C. M., GRIFFIN, D. E., BURKE, P. J., & LIETMAN, P. S. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-6-773 · Cited by 191
Cyclophosphamide metabolism is affected by azole antifungals
Marr, K. A., Leisenring, W., Crippa, F., Slattery, J. T., Corey, L., Boeckh, M., & McDonald, G. B. (2004) · Blood · doi:10.1182/blood-2003-07-2512 · Cited by 190
Self-citationDesJardin, J. A., Falagas, M. E., Ruthazer, R., Griffith, J., Wawrose, D., Schenkein, D., Miller, K., & Snydman, D. R. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-9-199911020-00002 · Cited by 177
Garcia-Carbonero, R., Mayordomo, J. I., Tornamira, M. V., Lopez-Brea, M., Rueda, A., Guillem, V., Arcediano, A., Yubero, A., Ribera, F., Gomez, C., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.1.31 · Cited by 177
Jaksic, B., Martinelli, G., Oteyza, J. P., Hartman, C. S., Leonard, L. B., & Tack, K. J. (2006) · Clinical Infectious Diseases · doi:10.1086/500139 · Cited by 170
Segal, B. H., Almyroudis, N. G., Battiwalla, M., Herbrecht, R., Perfect, J. R., Walsh, T. J., & Wingard, J. R. (2007) · Clinical Infectious Diseases · doi:10.1086/510677 · Cited by 168
Self-citationOliveira, A. L., de Souza, M., Carvalho-Dias, V. M. H., Ruiz, M. A., Silla, L., Tanaka, P. Y., Simões, B. P., Trabasso, P., Seber, A., Lotfi, C. J., et al. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705677 · Cited by 168
Cometta, A., Kern, W. V., De Bock, R., Paesmans, M., Vandenbergh, M., Crokaert, F., Engelhard, D., Marchetti, O., Akan, H., Skoutelis, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376637 · Cited by 168
Mattiuzzi, G. N., Alvarado, G., Giles, F. J., Ostrosky-Zeichner, L., Cortes, J., O'Brien, S., Verstovsek, S., Faderl, S., Zhou, X., Raad, I. I., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.143-147.2006 · Cited by 168
Self-citationAn approach to intensive antileukemia therapy in patients with previous invasive aspergillosis
Karp, J. E., Burch, P. A., & Merz, W. G. (1988) · The American Journal of Medicine · doi:10.1016/s0002-9343(88)80343-7 · Cited by 164
Pinto, L., Liu, Z., Doan, Q., Bernal, M., Dubois, R., & Lyman, G. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x219599 · Cited by 163
Histoplasmosis-Associated Cross-Reactivity in the BioRad Platelia Aspergillus Enzyme Immunoassay
Wheat, L. J., Hackett, E., Durkin, M., Connolly, P., Petraitiene, R., Walsh, T. J., Knox, K., & Hage, C. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00479-06 · Cited by 162
Staphylococcus aureus bacteremia in patients with Hickman catheters
Dugdale, D. C., & Ramsey, P. G. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90290-t · Cited by 161
Winston, D. J., Ho, W. G., Bruckner, D. A., & Champlin, R. E. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-11-849 · Cited by 161
DiazGranados, C. A., & Jernigan, J. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/427512 · Cited by 160
Management of central venous catheters in patients with cancer and candidemia
Raad, I., Hanna, H., Boktour, M., Girgawy, E., Danawi, H., Mardani, M., Kontoyiannis, D., Darouiche, R., Hachem, R., & Bodey, G. P. (2004) · Clinical Infectious Diseases · doi:10.1086/382874 · Cited by 159
Self-citationCiprofloxacin in pediatrics: worldwide clinical experience based on compassionate use-safety report
HAMPEL, B., HULLMANN, R., & SCHMIDT, H. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199701000-00036 · Cited by 158
Outcomes and Cost of Outpatient or Inpatient Management of 712 Patients With Febrile Neutropenia
Elting, L. S., Lu, C. S., Escalante, C. P., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8222 · Cited by 157
Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients
Mullen, C. A., Petropoulos, D., Roberts, W. M., Rytting, M., Zipf, T. F., Chan, K. W., Culbert, S. J., Danielson, M., Jeha, S. S., Kuttesch, J. F., et al. (1999) · Cancer · Cited by 155
Self-citationBenoit, J.-L., Carandang, G., Sitrin, M. D., & Arnow, P. M. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.5.1286 · Cited by 154
Quantitative blood cultures in the evaluation of septicemia in children with Broviac catheters
Raucher, H. S., Hyatt, A. C., Barzilai, A., Harris, M. B., Weiner, M. A., LeLeiko, N. S., & Hodes, D. S. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80584-3 · Cited by 153
Cattaneo, C. M., Quaresmini, G., Casari, S., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm514 · Cited by 153
Kern, W. V., Klose, K., Jellen-Ritter, A., et al. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-1278-x · Cited by 152
Gardner, A., Mattiuzzi, G. N., Faderl, S. H., Borthakur, G. M., Garcia‐Manero, G., Pierce, S. A., Brandt, M., & Estey, E. H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.4681 · Cited by 152
Favero, A. D., Menichetti, F., Martino, P., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/322646 · Cited by 150
Vancomycin‐ResistantStaphylococcus aureusin the Absence of Vancomycin Exposure
Whitener, C., Park, S. Y., Browne, F. A., Parent, L. J., Julian, K. G., Bozdoğan, B., Appelbaum, P. C., Chaitram, J. M., Weigel, L. M., Jernigan, J. A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/382357 · Cited by 148
Pinel, C., Fricker‐Hidalgo, H., Lebeau, B., Garban, F., Hamidfar, R., Ambroise-Thomas, P., & Grillot, R. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.5.2184-2186.2003 · Cited by 146
von Lilienfeld‐Toal, M., Dietrich, M. P., Glasmacher, A. G., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1156-y · Cited by 146
Loehrer, P. J. (2008) · Yearbook of Oncology · doi:10.1016/s1040-1741(08)79021-3 · Cited by 144
Symeonidis, N., Jakubowski, A. A., Pierre‐Louis, S., et al. (2007) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2006.00184.x · Cited by 143
Kanda, Y., Yamamoto, R., Chizuka, A., Hamaki, T., Suguro, M., Arai, C., Matsuyama, T., Takezako, N., Miwa, A., Kern, W., et al. (2000) · PubMed · Cited by 137
Malik, I. A., Malik, I. A., Abbas, Z., et al. (1992) · The Lancet · doi:10.1016/0140-6736(92)90674-r · Cited by 137
Fleming, R. V., Kantarjian, H. M., Husni, R., Rolston, K. V. I., Lim, J. T., RAAD, I. I., Pierce, S. A., Cortes, J. E., & Estey, E. H. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109097650 · Cited by 134
Self-citationEmpiric antibiotic therapy for granulocytopenic cancer patients.
Sc, S. (1986) · PubMed · Cited by 133
Innes, H., Smith, D. B., O'Reilly, S. M., CLARK, P. I., Kelly, V., & Marshall, E. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600993 · Cited by 133
Bacteremic Pneumonia in Neutropenic Patients With Cancer
Carratalà, J., Rosón, B., Fernández-Sevilla, A., Alcaide, F., & Gudiol, F. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.8.868 · Cited by 132
Reuter, S., Kern, W. V., Sigge, A., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/428732 · Cited by 131
Razonable, R. R., Litzow, M. R., Khaliq, Y., Piper, K. E., Rouse, M. S., & Patel, R. (2002) · Clinical Infectious Diseases · doi:10.1086/340352 · Cited by 130
Vardakas, K. Z., Michalopoulos, A. S., & Falagas, M. E. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05727.x · Cited by 129
Prophylactic action of oral fluconazole against fungal infection in neutropenic patients
Kanda, Y., Yamamoto, R., Chizuka, A., Hamaki, T., Suguro, M., Arai, C., Matsuyama, T., Takezako, N., Miwa, A., Kern, W., et al. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1611::aid-cncr27>3.0.co;2-b · Cited by 128
Bow, E. J., Rotstein, C., Noskin, G. A., re, M. L., Schwarer, A. P., Segal, B. H., Seymour, J. F., Szer, J., & Sanche, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/505393 · Cited by 127
Self-citationHanna, H. A., Afif, C., Alakech, B., et al. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502455 · Cited by 126
Seifert, H., Cornely, O. A., Seggewiss, K., Decker, M., Stefanik, D., Wisplinghoff, H., & Fätkenheuer, G. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.118-123.2003 · Cited by 122
Masaoka, T. (2004) · Clinical Infectious Diseases · doi:10.1086/383054 · Cited by 122
Johnson, D., Johnson, F. L., & Goldman, S. (1994) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199410000-00015 · Cited by 121
New Trends in Patient Management: Risk-Based Therapy for Febrile Patients with Neutropenia
Rolston, K. V. I. (1999) · Clinical Infectious Diseases · doi:10.1086/598624 · Cited by 119
Self-citationHebart, H. F., Klingspor, L., Klingebiel, T. E., Loeffler, J., Tollemar, J. G., Ljungman, P. T., Wandt, H., Schaefer‐Eckart, K., Dornbusch, H. J., Meisner, C., et al. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.355 · Cited by 117
Portugal, R. D., Garnica, M. M., & Nucci, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.0856 · Cited by 117
Cordonnier, C., Maury, S., Pautas, C., Bastié, J. N., Chehata, S., Castaigné, S., Kuentz, M., Bretagne, S., & Ribaud, P. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704469 · Cited by 116
Rapid diagnosis of invasive aspergillosis by antigen detection
Wheat, L. J. (2003) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2003.00031.x · Cited by 116
New antimicrobial agents for the treatment of Gram-positive bacterial infections
Aksoy, D. Y., & Ünal, S. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01933.x · Cited by 115
Influenza immunization of adult patients with malignant diseases.
Ortbals, D., Liebhaber, H., Presant, C., van Amburg, A., & Lee, J. Y. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-5-552 · Cited by 115
Meunier, F., Zinner, S. H., Gaya, H., et al. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.5.873 · Cited by 112
Treatment of Hickman Catheter Sepsis Using Antibiotic Lock Technique
Krzywda, E. A., Andris, D. A., Edmiston, C. E., & Quebbeman, E. J. (1995) · Infection Control and Hospital Epidemiology · doi:10.1086/647015 · Cited by 111
Hidalgo, M. M., Hornedo, J., Lumbreras, C., et al. (1999) · PubMed · Cited by 110
Respiratory syncytial virus infection following hematopoietic stem cell transplantation
Small, T., Casson, A., Malak, S., Boulad, F., Kiehn, T. E., Stiles, J., Ushay, H. M., & Sepkowitz, K. A. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703365 · Cited by 109
Self-citationNordøy, T., Aaberge, I. S., Husebekk, A., Samdal, H. H., Steinert, S., Melby, H., & Kolstad, A. (2002) · Medical Oncology · doi:10.1385/mo:19:2:71 · Cited by 107
Utility of Influenza Vaccination for Oncology Patients
Pollyea, D. A., Brown, J. W., & Horning, S. J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.6908 · Cited by 105
Noel, G. J., Bradley, J. S., Kauffman, R. E., et al. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3180cbd382 · Cited by 104
Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
Lebeaux, D., Lanternier, F., Elie, C., Suárez, F., Buzyn, A., Viard, J., Bougnoux, M., Lecuit, M., Jullien, V., & Lortholary, O. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00939-09 · Cited by 104
Bow, E. J., Loewen, R., Cheang, M., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2254 · Cited by 103
Self-citationRAAD, I. I., Buzaid, A. C., Rhyne, J. A., Hachem, R. Y., Darouiche, R. O., Safar, H., Albitar, M. X., & Sherertz, R. J. (1997) · Clinical Infectious Diseases · doi:10.1086/514518 · Cited by 102
Self-citationPaul, M., Borok, S., Fraser, A., Vidal, L., & Leibovici, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki028 · Cited by 101
Gil, L., Styczyński, J., & Komarnicki, M. A. (2007) · Infection · doi:10.1007/s15010-007-6350-2 · Cited by 100
Limaye, A. P., Huang, M.-L. W., Leisenring, W. M., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/318089 · Cited by 100
Feld, R. D., dePauw, B. E., Berman, S., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.21.3690 · Cited by 99
Vehreschild, J. J., Böhme, A., Buchheidt, D., Arenz, D., Harnischmacher, U., Heußel, C. P., Ullmann, A. J., Mousset, S., Hummel, M., Frommolt, P., et al. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.07.003 · Cited by 99
Respiratory Virus Infections in Adults with Hematologic Malignancies: A Prospective Study
Martino, R., Rámila, E., Rabella, N., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/344899 · Cited by 99
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Groll, A. H., Castagnola, E., Cesaro, S., Dalle, J.-H., Engelhard, D., Hope, W., Roilides, E., Styczynski, J., Warris, A., & Lehrnbecher, T. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70017-8 · Cited by 407
Schiffer, C. A., Mangu, P. B., Wade, J. C., Camp-Sorrell, D., Cope, D. G., El-Rayes, B. F., Gorman, M., Ligibel, J., Mansfield, P., & Levine, M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.5733 · Cited by 368
Montassier, E., Batard, E., Gastinne, T., Potel, G., & Cochetière, M. F. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1819-7 · Cited by 304
Metadata
- Authors
- Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-15
- Volume
- 52
- Issue
- 4
- Pages
- 427-431
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2096598041
- Cited by
- 704
- References
- 320
- FWCI
- 22.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.